Patrick J. Oleary - 27 Jul 2026 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Reporting relationship: Director
Issuer ticker: AVNS
Reported as of: 27 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jul 2026, 17:37:40 UTC
Prior SEC filing: 14 May 2026
Source filing: View source filing
Reporting owner signature: /s/ John Fischer, as attorney-in-fact for Patrick J. O'Leary

Key filing fact

Patrick J. Oleary filed Form 4 for AVANOS MEDICAL, INC. (AVNS) on 28 Jul 2026.

Key facts

This page summarizes Patrick J. Oleary's Form 4 filing for AVANOS MEDICAL, INC. (AVNS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Jul 2026, 17:37.

Change

Previous filing in this sequence was filed on 14 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001248039 Primary reporting owner

OLEARY PATRICK J

Relationship: Director
Address: 5405 WINDWARD PARKWAY, ALPHARETTA
Signature: /s/ John Fischer, as attorney-in-fact for Patrick J. O'Leary
Signature date: 28 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVNS transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -54,640
Change %: -100%
Price: $25.00^*
Shares after: 0
Date: 27 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVNS transaction Derivative

Restricted Share Units

Disposed to Issuer

Transaction value
Shares: -12,003
Change %: -100%
Price: $25.00^*
Shares after: 0
Date: 27 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,003
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Patrick J. Oleary is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement.

Footnote F2

Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock.

Footnote F3

Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings).